Surgical treatment options following chemotherapy plus cetuximab or bevacizumab in metastatic colorectal cancer—central evaluation of FIRE-3. - Modest, D.P.; Denecke, T.; Pratschke, J.; Ricard, I.; Lang, H.; Bemelmans, M.; Becker, T.; Rentsch, M.; Seehofer, D.; Bruns, C.J.; Gebauer, B.; Modest, H.I.; et al. (European Journal of Cancer, 2018)